Obesity may be erythropoietin dose-saving in hemodialysis patients

BACKGROUND: In dialysis patients, the obesity-survival paradox still requires an explanation. Anemia and high doses of erythropoiesis-stimulating agents (ESAs) are associated with worse outcomes in the hemodialysis (HD) population. In the present study, we explored the relation between obesity and a...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kannishy, Ghada M., Megahed, Abir F., Tawfik, Mona M., El-Said, Ghada, Zakaria, Rabab T., Mohamed, Nahed A., Taha, Eman M., Ammar, Alzhraa A., Abd Eltawab, Abeer M., Sayed-Ahmed, Nagy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Nephrology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027808/
https://www.ncbi.nlm.nih.gov/pubmed/29971210
http://dx.doi.org/10.23876/j.krcp.2018.37.2.148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027808/
https://www.ncbi.nlm.nih.gov/pubmed/29971210
http://dx.doi.org/10.23876/j.krcp.2018.37.2.148

Ejemplares similares